Vivek Ramaswamy strikes again, this time launching a Beijing-based biotech player with a pipeline
Another day, another startup at Vivek Ramaswamy’s Roivant. And this time he’s underscoring the global nature of the industry and his business strategy, as China’s biotech scene explodes with fresh cash and some familiar drugs.
This morning Roivant unveiled Sinovant along with CITICPE, a Chinese private equity group. This company is based in Beijing and Shanghai, and it’s been assembling an executive crew and pipeline for today’s announcement.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.